source
- Geopolitical uncertainty dampens UK biotech IPO outlook despite record Q2 venture fundingGeopolitical uncertainty continues to weigh on the sentiment around initial public offerings for British biotech companies, according to an industry leader speaking to Fierce. At the same time, th…
- Abbott reports cyberattack on cancer diagnostics and LabCentral portal, says operations unaffectedAbbott announced that a cyber incident on July 16 accessed a limited number of internal systems in its cancer diagnostics unit. The company said the breach does not affect product availability, ma…